BDO Wealth Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

BDO Wealth Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-125	Closed	-$6K	–	611
2018 Q4	$6K	Hold	125	–	–	﹤0.01%	440
2018 Q3	$7K	Hold	125	–	–	﹤0.01%	482
2018 Q2	$8K	Hold	125	–	–	﹤0.01%	481
2018 Q1	$7K	Hold	125	–	–	﹤0.01%	419
2017 Q4	$8K	Hold	125	–	–	﹤0.01%	348
2017 Q3	$7K	Hold	125	–	–	﹤0.01%	323
2017 Q2	$6K	Buy	+125	New	+$6.03K	﹤0.01%	412

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BDO Wealth Advisors's ANIP Position: Q1 2019 in Review

BDO Wealth Advisors sold out of ANI Pharmaceuticals (ANIP) in Q1 2019, closing a stake of 125 shares — an estimated $6K sold.

BDO Wealth Advisors first reported a position in ANIP in Q2 2017 and held it in 7 quarters. The position peaked at $8K in Q2 2018. 190 funds tracked by Wall St. Rank hold ANIP as of Q1 2019.

BDO Wealth Advisors reported no remaining ANI Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
BDO Wealth Advisors sold 125 ANI Pharmaceuticals shares in Q1 2019, an estimated $6K.
BDO Wealth Advisors first reported a position in ANI Pharmaceuticals in Q2 2017 and held it in 7 quarters.
BDO Wealth Advisors's ANI Pharmaceuticals position peaked at $8K in Q2 2018.
190 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2019.

Based on BDO Wealth Advisors's 13F filing for Q1 2019, filed 15 May 2019.